Waldman Lawrence
Transaction: 06/30/2026
SELL
Change
-12,000
Price
$1.88
Filing
07/02/2026
Type
SELL
Apyx Medical Corporation
APYX • Medical - Specialties
$3.05
▼ -0.01 (-0.33%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$128.60M
Growth
1.9%
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 5High debt level · 2.71Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:38 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.05
Change-0.33%
Shares Out42.16M
Market Cap$128.60M
Enterprise Value$136.31M
52W Range1.70 - 5.08
Beta1.37
P/E-14.89
P/S2.20
P/B12.06
P/FCF-11.01
EV/Sales2.33
Price$3.05
Change-0.33%
Shares Out42.16M
Market Cap$128.60M
Enterprise Value$136.31M
52W Range1.70 - 5.08
Beta1.37
P/E-14.89
P/S2.20
P/B12.06
P/FCF-11.01
EV/Sales2.33
EV/EBITDA-57.68
EV/FCF-11.67
Earnings Yield-6.71%
FCF Yield-9.08%
Dividend Yield0.00%
Gross Margin36.02%
Oper. Margin-12.20%
Profit Margin-21.22%
Debt/Eq2.71
Current Ratio5.00
Quick Ratio4.26
Revenue 5Y1.86%
Target$6.50
Target Upside113.11%
Target Median$6.50
Target Range6.00 - 7.00
Volume74.57K
Avg Volume158.79K
EPS Surprise0.06
Investment DNA
How strong this company looks for long-term investors
32
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
58/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Healthy liquidity · 5High debt level · 2.71Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 9 analyst votes · 2026-09-05
94/100
Bullish
Bullish
8
Hold
1
Bearish
0
Price Target
2026-08-07
Low
$6.00
Mean
$6.50
Median
$6.50
High
$7.00
Insider Transactions
Recent executive and insider activity
Waldman Lawrence
Transaction: 06/30/2026
SELL
Change
-5,024
Price
$4.49
Filing
07/02/2026
Type
SELL
Roman Shawn David
Transaction: 06/15/2026
SELL
Change
-15,000
Price
$3.23
Filing
06/17/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Waldman Lawrence | SELL | -12,000 | $1.88 | 06/30/2026 | 07/02/2026 |
| Waldman Lawrence | SELL | -5,024 | $4.49 | 06/30/2026 | 07/02/2026 |
| Roman Shawn David | SELL | -15,000 | $3.23 | 06/15/2026 | 06/17/2026 |
| Roman Shawn David | BUY | +15,000 | $3.23 | 06/15/2026 | 06/17/2026 |
| CITRONOWICZ MOSHE | BUY | +63,392 | $4.65 | 06/11/2026 | 06/15/2026 |
| HILL MATTHEW C | BUY | +132,066 | $4.65 | 06/11/2026 | 06/15/2026 |
| Waldman Lawrence | BUY | +50,000 | $4.65 | 06/11/2026 | 06/15/2026 |
| Baylor-Henry Minnie | BUY | +50,000 | $4.65 | 06/11/2026 | 06/15/2026 |
| Roman Shawn David | BUY | +88,044 | $4.65 | 06/11/2026 | 06/15/2026 |
| Goodwin Charles D. II | BUY | +213,948 | $4.65 | 06/11/2026 | 06/15/2026 |
| Vizirgianakis Stavros G. | BUY | +450,000 | Not reported | 06/11/2026 | 06/15/2026 |
| Levine Wendy Lauren | BUY | +50,000 | $4.65 | 06/11/2026 | 06/15/2026 |
| CITRONOWICZ MOSHE | SELL | -37,000 | $1.80 | 03/15/2026 | 03/17/2026 |
| CITRONOWICZ MOSHE | BUY | +37,000 | $1.80 | 03/15/2026 | 03/17/2026 |
| Roman Shawn David | SELL | -12,000 | $1.80 | 01/27/2026 | 01/29/2026 |
| Roman Shawn David | BUY | +12,000 | $1.80 | 01/27/2026 | 01/29/2026 |
| Levine Wendy Lauren | BUY | +64,000 | $1.48 | 05/15/2025 | 05/19/2025 |
| Goodwin Charles D. II | BUY | +193,000 | $1.48 | 05/15/2025 | 05/19/2025 |
| Vizirgianakis Stavros G. | BUY | +128,000 | $1.48 | 05/15/2025 | 05/19/2025 |
| Baylor-Henry Minnie | BUY | +59,000 | $1.48 | 05/15/2025 | 05/19/2025 |